ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3204

Hypoechoic Lesions on Parotid Gland Ultrasound Are a Surrogate Marker of Focal Lymphocytic Sialadenitis on Minor Salivary Gland Biopsy in Sjögren’s Syndrome

Thomas Grader-Beck1, Joel Fradin2, Jean Kim3, Esen Akpek4, Brendan Antiochos5, Julius Birnbaum6 and Alan N. Baer7, 1Medicine Div of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 2Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, 3Otolaryngology, Head & Neck Surgery, Johns Hopkins University, Baltimore, MD, 4Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, 5Medicine-Division of Rheumatology, Johns Hopkins University, Baltimore, MD, 6Medicine (Rheumatology), Johns Hopkins University School of Medicine, Baltimore, MD, 7Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: biopsies and ultrasound, Sjogren's syndrome

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Sjögren's Syndrome II: Clinical Discoveries

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: To determine whether hypoechoic lesions on parotid gland ultrasound can serve as
a surrogate marker for a focus score ≥1 on minor salivary gland biopsy in
patients with suspected Sjogren’s syndrome (SS).

Methods: We analyzed 220 parotid gland salivary gland
ultrasounds that were obtained on 220 patients being evaluated for possible or
known SS at the Johns Hopkins Sjogren’s Center
between 2012 and 2015. All scans were performed and interpreted by a
radiologist (JF) with expertise in ultrasonography.  The presence of hypoechoic lesions within the parotid gland parenchyma was
determined in each scan. Sjogren’s syndrome (SS) was
diagnosed according to AECG or preliminary ACR criteria. Statistical analyses
were performed using Fisher’s exact and Student’s t-test.

Results: Among the 220 patients, 116 fulfilled
classification criteria for SS. The remaining patients were labeled as “sicca controls”. Hypoechoic lesions
were significantly more frequent in SS patients versus controls (55/116 versus
3/104; p <0.0001) resulting in a sensitivity of 47% and specificity of 97%
for SS. A minor salivary gland biopsy was performed in 64 patients with SS and
showed a focus score ≥ 1 in 51 (80%). The presence of hypoechoic
lesions on ultrasound was highly associated with FLS ≥1 (23/24 versus
28/40, OR 9.9; 95% CI 1.2-81.5). The mean focus score was not significantly
different in SS patients with hypoechoic lesions compared
to SS patients without hypoechoic lesions (3.22
versus 2.39, p=ns). Positive
autoantibody status (anti-SSA/SSB/rheumatoid factor, hypergammaglobulinemia)
as well as leukopenia, monoclonal gammopathy and
salivary gland swelling were significantly more frequent in SS patients with hypoechoic lesions, whereas there was no difference in
frequency of C3 and C4 hypocomplementemia or symptom
duration. Other features on parotid gland ultrasound, including heterogeneity,
calcifications and presence of cysts did not predict FLS ≥ 1 as
accurately as hypoechoic lesions. Moreover, addition
of submandibular gland ultrasound data did not add additional predictive value.

Conclusion: Hypoechoic
lesions on parotid gland ultrasound strongly correlate with the presence of a
focus score ≥1 on minor salivary gland biopsy. Larger studies are needed
to determine whether ultrasound imaging may replace a diagnostic lip biopsy in
subsets of patients evaluated for SS.

 


Disclosure: T. Grader-Beck, None; J. Fradin, None; J. Kim, None; E. Akpek, None; B. Antiochos, None; J. Birnbaum, None; A. N. Baer, Glenmark Pharmaceuticals, 9.

To cite this abstract in AMA style:

Grader-Beck T, Fradin J, Kim J, Akpek E, Antiochos B, Birnbaum J, Baer AN. Hypoechoic Lesions on Parotid Gland Ultrasound Are a Surrogate Marker of Focal Lymphocytic Sialadenitis on Minor Salivary Gland Biopsy in Sjögren’s Syndrome [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/hypoechoic-lesions-on-parotid-gland-ultrasound-are-a-surrogate-marker-of-focal-lymphocytic-sialadenitis-on-minor-salivary-gland-biopsy-in-sjogrens-syndrome/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hypoechoic-lesions-on-parotid-gland-ultrasound-are-a-surrogate-marker-of-focal-lymphocytic-sialadenitis-on-minor-salivary-gland-biopsy-in-sjogrens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology